Effects of the Novel Antidepressant Milnacipran in a Chronic Mild Stress Model of Depression

Drug Development Research

Volumn 61, Issue 2, 2004, Pages 101-106

  Papp, Mariusz ^a   Panconi, Emmanuel ^b   Gruca, Piotr ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Antidepressant; Chronic mild stress; Depression model; Milnacipran; Rats anhedonia

Indexed keywords

IMIPRAMINE; MILNACIPRAN; SUCROSE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; INJECTION; MALE; NONHUMAN; PSYCHOPHARMACOLOGY; RAT; REWARD; STRESS;

EID: 1542373581     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10340     Document Type: Article

References (20)

1. Briley M, Moret C. 1997. Antidepressant properties of specific serotonin-noradrenaline reuptake inhibitors. In: Skolnick P, editor. Antidepressants: new pharmacological strategies. Totowa: Humana Press, p 35-52.
2. Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL, Hemrick-Luecke SK, Wong DT. 2001 Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes and other neuronal systems. Neuropsychopharmacology 25:871-879.
3. Feeney A, Nutt DJ. 1999. The neuropharmacology of serotonin and noradrenaline in depression. Int J Psychiat Clin Pract 3:S3-S8.
4. Leonard BE. 1998. Animal models of depression. In: Briley M, Montgomery S, editors. Antidepressant therapy at the dawn of the third millennium. London: Martin Dunitz, p 87-109.
5. Marona-Lewicka D, Nichols DE. 1997. The effect of selective serotonin releasing agents in the chronic mild stress model of depression in rats. Stress 2:91-100.
6. McKinney WT. 1977. Biobehavioural models of depression in monkeys. In: Hanin I, Usdin E, editors. Animal models in psychiatry and neurology. Oxford: Pergamon Press, p 359-368.
7. Millan MJ, Dekeyne A, Papp M, La Rochelle CD, MacSweeny C, Peglion JL, Brocco M. 2001. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J Pharmacol Exp Ther 298:581-591.
8. Monleon S, D'Aquila P, Parra A, Simon VM, Brain PF, Willner P. 1995. Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology 117:453-457.
9. Montgomery SA. 1995. Rapid onset of action of venlafaxine. Int Clin Psychopharmacol 10(Suppl 2):21-7.
10. Montgomery SA, Loft H, Sanchez C, Reines EH, Papp M. 2001. Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model. Pharmacol Toxicol 88:282-286.
11. Moret C, Charveron M, Finberg JP, Couzinier JP, Briley M. 1985. Biochemical profile of milnacipran (F2207), 1-phenyl-1 -diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug. Neuropharmacology 24:1211-1219.
12. Papp M, Wieronska J. 2000. Antidepressant-like activity of amisulpride in two animal models of depression. J Psychopharmacol 14:46-52.
13. Puech A, Montgomery SA, Prost JF, Solles A, Briley M. 1997. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability. Int Clin Psychopharmacol 12:99-108.
14. Stahl SM, Nierenberg AA, Gorman JM. 2001. Evidence of early onset of antidepressant effect in randomized controlled trials. J Clin Psychiatry 62(Suppl 4):17-23.
15. Willner P. 1987. Sensitization to the actions of antidepressant drugs. In: Emmett-Oglesby MW, Goudie AJ, editors. Tolerance and sensitization to psychoactive drugs. Clifton: Humana Press, p 116-124.
16. Willner P. 1990. Animal models of depression: an overview. Pharmacol Ther 45:425-455.
17. Willner P. 1991. Animal models as simulators of depression. Trends Pharmacol Sci 12:131-136.
18. Willner P. 1995. Animal models of depression: validity and applications. In: Gessa GL, Fratta W, Paris L, Serra G, editors. Depression and mania: from neurobiology to treatment. New York: Raven Press, p 19-42.
19. Willner P. 1997. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134:319-329.
20. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R. 1987. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 93:358-364.